Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03928678
Other study ID # 458
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 1, 2019
Est. completion date December 1, 2020

Study information

Verified date April 2020
Source Assiut University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of our study is to determine the effect of implementation of the ERAS (enhanced recovery after surgery) protocol in our institute and its impact on hospital length of stay and outcome of surgery.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date December 1, 2020
Est. primary completion date November 1, 2020
Accepts healthy volunteers No
Gender All
Age group 18 Years to 60 Years
Eligibility Inclusion Criteria: - Age = 60 years, - Good nutrition, - No systemic infection and - Elective laparoscopic surgery Exclusion Criteria: - Age >75 years, - Malnutrition or an organ system infection - Associated with obstruction, bleeding, emergency surgery or other surgical intervention - Tumor with extensive metastasis - Prior to surgery, patient was fasting, underwent gastrointestinal decompression and received nutritional support - Previous history of abdominal surgery - Patient have previously undergone gastrostomy

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
enhanced recovery after surgery program in colorectal cancer surgery
to determine the feasibility of implementation of the ERAS protocol in our institute and its impact on hospital length of stay and outcome of surgery.

Locations

Country Name City State
Egypt South Egypt Cancer Instuite Assuit

Sponsors (1)

Lead Sponsor Collaborator
Assiut University

Country where clinical trial is conducted

Egypt, 

Outcome

Type Measure Description Time frame Safety issue
Primary length of hospital stay in days length of hospital stay in days 4 days
See also
  Status Clinical Trial Phase
Recruiting NCT05982184 - Effect of Music Prehabilitation on Preoperative Anxiety Before Surgery N/A
Completed NCT04160650 - Educational Nursing Intervention Among Patients With Colorectal Cancer During Chemotherapy N/A
Recruiting NCT05179824 - Tempus Priority Study: A Pan-tumor Observational Study
Completed NCT04716010 - Developing and Evaluating Product Messaging N/A
Terminated NCT03524820 - Cetuximab Therapy for Third Line Rechallenge in Metastatic Colorectal Cancer Phase 2
Active, not recruiting NCT02458664 - BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer N/A
Completed NCT03246438 - Choice Architecture and Colorectal Cancer Screening Outreach N/A
Recruiting NCT04028479 - The Registry of Oncology Outcomes Associated With Testing and Treatment
Not yet recruiting NCT03910283 - Leveraging Mindsets to Improve Health & Wellbeing in Patients With Cancer N/A
Completed NCT03546569 - Tumor Cells, Tumor DNA and Immunological Response in Colonic Stent Placement
Recruiting NCT03896958 - The PIONEER Initiative: Precision Insights On N-of-1 Ex Vivo Effectiveness Research Based on Individual Tumor Ownership (Precision Oncology)
Not yet recruiting NCT06035731 - Evaluation of the Medical Service by Socio-aesthetics in Oncology N/A
Completed NCT04971304 - Comparative Effectiveness Analysis of Granulocyte Colony Stimulating Factor Originator Products Versus Biosimilars
Completed NCT05030090 - Integrative Nutrition Care Plan for the Patient With Liver and Colorectal Cancer N/A
Not yet recruiting NCT04773626 - Tumor Deposits in Cancer Colon
Recruiting NCT05887531 - Abdominopelvic Cancer Prehabilitation N/A
Withdrawn NCT04274790 - Impact of 5-Fluorouracil (5-FU) on Cancer Cells From Liver Metastases of Colon Cancer
Completed NCT03416777 - Meat-based Versus Pesco-vegetarian Diet and Colorectal Cancer N/A
Completed NCT03210129 - Motivational Interviewing to Increase Physical Activity Behaviour in Cancer Patients N/A
Recruiting NCT00294476 - IVIG in the Treatment of Metastatic Cancers of the Prostate, Colon and Melanoma Phase 2